Reduced antiplatelet drug responsiveness, including resistance to currently used oral antiplatelet agents, has been suggested to play a role in these worse outcomes.

• 降低抗血小板药物反应性已被认为在这些更糟的结果的出现中起到了推波助澜的作用，其中就包括对目前常用口服抗血小板剂的抵制。